Low-molecular-weight methylcellulose-based thermo-reversible gel/pluronic micelle combination system for local and sustained docetaxel delivery

Pharmaceutical Research

Volumn 29, Issue 2, 2012, Pages 525-534

  Kim, Jang Kyoung ^a   Won, Young Wook ^a   Lim, Kwang Suk ^a   Kim, Yong Hee ^a  

^a Hanyang University   (South Korea)

Author keywords

Cancer therapy; Docetaxel; Drug delivery; Gel micelle combination system; Methylcellulose

Indexed keywords

DOCETAXEL; METHYLCELLULOSE; POLOXAMER; ANTINEOPLASTIC AGENT; TAXOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; GEL; LOW MOLECULAR WEIGHT METHYLCELLULOSE BASED THERMO REVERSIBLE GEL; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE MICELLE; SURVIVAL; SUSTAINED RELEASE FORMULATION; TUMOR CELL; TUMOR VOLUME; ANIMAL; C57BL MOUSE; CHEMISTRY; DELAYED RELEASE FORMULATION; MICELLE; NEOPLASM;

ANIMALS; ANTINEOPLASTIC AGENTS; DELAYED-ACTION PREPARATIONS; MALE; METHYLCELLULOSE; MICE; MICE, INBRED C57BL; MICELLES; NEOPLASMS; POLOXAMER; TAXOIDS;

EID: 84860850040     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-011-0581-8     Document Type: Article

References (35)

1. Jeong B, Bae YH, Lee DS, Kim SW. Biodegradable block copolymers as injectable drug-delivery systems. Nature. 1997;388(6645):860-2.
2. Zahedi P, De Souza R, Piquette-Miller M, Allen C. Chitosanphospholipid blend for sustained and localized delivery of docetaxel to the peritoneal cavity. Int J Pharm. 2009;377(1-2):76-84.
3. Vukelja S, Anthony S, Arseneau J, Berman B, Casey Cunningham C, Nemunaitis J, et al. Phase 1 study of escalating-dose OncoGel (R)(ReGel (R)/paclitaxel) depot injecmanagement of superficial solid tumor lesions. Anti-cancer Drugs. 2007;18(3):283-89.
4. Cho K, Wang X, Nie S, Chen Z, Shin D. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res. 2008;14(5):1310-16.
5. Jackson JK, Zhang X, Llewellen S, Hunter WL, Burt HM. The characterization of novel polymeric paste formulations for intratumoral delivery. Int J Pharm. 2004;270(1-2):185-98.
6. Nsereko S, Amiji M. Localized delivery of paclitaxel in solid tumors from biodegradable chitin microparticle formulations. Biomaterials. 2002;23(13):2723-31.
7. Ranganath SH, Wang C-H. Biodegradable microfiber implants delivering paclitaxel for post-surgical chemotherapy against malignant glioma. Biomaterials. 2008;29(20):2996-3003.
8. Shim WS, Kim J-H, Kim K, Kim Y-S, Park R-W, Kim I-S, et al. pH- and temperature-sensitive, injectable, biodegradable block copolymer hydrogels as carriers for paclitaxel. Int J Pharm. 2007;331(1):11-8.
9. Lim Soo P, Cho J, Grant J, Ho E, Piquette-Miller M, Allen C. Drug release mechanism of paclitaxel from a chitosan-lipid implant system: effect of swelling, degradation and morphology. Eur J Pharm Biopharm. 2008;69(1):149-57.
10. Yang Y, Wang J, Zhang X, Lu W, Zhang Q. A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel. J Control Release. 2009;135(2):175-82.
11. Heller J. Patient-friendly bioerodible drug delivery systems. J Control Release. 2009;133(2):88-9.
12. Klouda L, Mikos A. Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm. 2008;68(1):34-45.
13. Jin K-M, Kim Y-H. Injectable, thermo-reversible and complex coacervate combination gels for protein drug delivery. J Control Release. 2008;127(3):249-56.
14. Won Y-W, Kim J-K, Cha M-J, Hwang K-C, Choi D, Kim Y-H. Prolongation and enhancement of the anti-apoptotic effects of PTD-Hsp27 fusion proteins using an injectable thermo-reversible gel in a rat myocardial infarction model. J Control Release. 2010;144(2):181-89.
15. Chen M-C, Tsai H-W, Liu C-T, Peng S-F, Lai W-Y, Chen S-J, et al. A nanoscale drug-entrapment strategy for hydrogel-based systems for the delivery of poorly soluble drugs. Biomaterials. 2009;30(11):2102-11.
16. Torchilin VP. Targeted polymeric micelles for delivery of poorly soluble drugs. Cell Mol Life Sci. 2004;61(19):2549-59.
17. Gou M, Li X, Dai M, Gong C, Wang X, Xie Y, et al. A novel injectable local hydrophobic drug delivery system: biodegradable nanoparticles in thermo-sensitive hydrogel. Int J Pharm. 2008;359(1-2):228-33.
18. Jeong B, Kim S, Bae Y. Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliv Rev. 2002;54(1):37-51.
19. Ruel-Gariépy E, Leroux J-C. In situ-forming hydrogels-review of temperature-sensitive systems. Eur J Pharm Biopharm. 2004;58(2):409-26.
20. Sezgin Z, Yüksel N, Baykara T. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Eur J Pharm Biopharm. 2006;64(3):261-68.
21. Li L, Lim LH, Wang Q, Jiang SP. Thermoreversible micellization and gelation of a blend of pluronic polymers. Polymer. 2008;49(7):1952-60.
22. Chiappetta DA, Sosnik A. Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs. Eur J Pharm Biopharm. 2007;66(3):303-17.
23. Engels F, Mathot R, Verweij J. Alternative drug formulations of docetaxel: a review. Anti-cancer Drugs. 2007;18(2):95-103.
24. Yang HN, Park JS, Na K, Woo DG, Kwon YD, Park K-H. The use of green fluorescence gene (GFP)-modified rabbit mesenchymal stem cells (rMSCs) co-cultured with chondrocytes in hydrogel constructs to reveal the chondrogenesis of MSCs. Biomaterials. 2009;30(31):6374-85.
25. Rao BM, Chakraborty A, Srinivasu MK, Devi ML, Kumar PR, Chandrasekhar KB, et al. A stability-indicating HPLC assay method for docetaxel. J Pharm Biomed Anal. 2006;41(2):676-81.
26. Andersen A, Warren D, Brunsvig P, Aamdal S, Kristensen G, Olsen H. High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection. BMC Clin Pharmacol. 2006;6(1):1-10.
27. Liu J, Zeng F, Allen C. Influence of serum protein on polycarbonate-based copolymer micelles as a delivery system for a hydrophobic anti-cancer agent. J Control Release. 2005;103(2):481-97.
28. Lee KY, Yuk SH. Polymeric protein delivery systems. Prog Polym Sci. 2007;32(7):669-97.
29. Kim SY, Kim JH, Kim D, An JH, Lee DS, Kim SC. Drug-releasing kinetics of MPEG/PLLA block copolymer micelles with different PLLA block lengths. J Appl Polym Sci. 2001;82(10):2599-605.
30. Jeong Y-I, Cheon J-B, Kim S-H, Nah J-W, Lee Y-M, Sung Y-K, et al. Clonazepam release from core-shell type nanoparticles in vitro. J Control Release. 1998;51(2-3):169-78.
31. Adden R, Melander C, Brinkmalm G, Gorton L, Mischnick P. New approaches to the analysis of enzymatically hydrolyzed methyl cellulose. Part 1. Investigation of the influence of structural parameters on the extent of degradation. Biomacromolecules. 2006;7(5):1399-409.
32. Melander C, Adden R, Brinkmalm G, Gorton L, Mischnick P. New approaches to the analysis of enzymatically hydrolyzed methyl cellulose. Part 2. Comparison of various enzyme preparations. Biomacromolecules. 2006;7(5):1410-21.
33. Hwang H-Y, Kim I-S, Kwon IC, Kim Y-H. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. J Control Release. 2008;128(1):23-31.
34. Won Y-W, Yoon S-M, Sonn CH, Lee K-M, Kim Y-H. Nano selfassembly of recombinant human gelatin conjugated with atocopheryl succinate for Hsp90 inhibitor, 17AAG, delivery. ACS Nano. 2011;5(5):3839-48.
35. Pasquier E, Honoré S, Braguer D. Microtubule-targeting agents in angiogenesis: Where do we stand? Drug Resist Update. 9(1-2):74-86.